Darwin Global Management

Latest statistics and disclosures from Darwin Global Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are INSM, BLTE, ABVX, CDTX, WVE, and represent 99.53% of Darwin Global Management's stock portfolio.
  • Added to shares of these 5 stocks: BLTE (+$487M), WVE (+$125M), INSM (+$83M), CAPR (+$23M), ABVX.
  • Started 3 new stock positions in BLTE, CAPR, WVE.
  • Reduced shares in these 2 stocks: , QURE (-$24M).
  • Sold out of its positions in UTHR, QURE.
  • Darwin Global Management was a net buyer of stock by $379M.
  • Darwin Global Management has $4.9B in assets under management (AUM), dropping by 37.29%.
  • Central Index Key (CIK): 0001839209

Tip: Access up to 7 years of quarterly data

Positions held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Darwin Global Management

Darwin Global Management holds 6 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Insmed Com Par $.01 (INSM) 73.8 $3.6B +2% 21M 174.09
 View chart
Belite Bio Sponsored Ads (BLTE) 9.9 $487M NEW 3.0M 160.82
 View chart
Abivax Sa Sponsored Ads (ABVX) 8.9 $440M 3.2M 138.34
 View chart
Cidara Therapeutics Com New (CDTX) 4.5 $220M 997k 220.80
 View chart
Wave Life Sciences SHS (WVE) 2.5 $125M NEW 7.3M 17.15
 View chart
Capricor Therapeutics Com New (CAPR) 0.5 $23M NEW 800k 28.96
 View chart

Past Filings by Darwin Global Management

SEC 13F filings are viewable for Darwin Global Management going back to 2020

View all past filings